Views & Analysis UK Pharmaceutical Leaders Survey 2017: Brace for Turbulence A look ahead to the UK market in 2017 through the eyes of pharma industry leaders
Views & Analysis Fast-track appraisals and Managed Access Agreements Experts discuss England’s proposed ‘fast-track’ appraisals for new treatments, plus MAAs.
Views & Analysis High-value, high-cost drugs: how to pay for them Experts call for urgent development of new drug funding mechanisms.
Views & Analysis Digital Health Round-up: Fitbit falters, NHS picks six winne... A round-up of this week’s top digital healthcare news. Marco Ricci reports.
News Mental health the focus of new £400K NHS England digital fun... Six to eight innovations will be chosen to take part in the Digital Development Lab.
Views & Analysis NICE and NHS England unveil ‘fast-track’ and affordability s... NHS England will be able to control cost impact of NICE decisions more directly.
News Lilly bags FDA okay for Wegovy pill rival orforglipron Eli Lilly has claimed US approval for oral GLP-1 agonist orforglipron, setting up a market clash with Novo Nordisk's first-to-market Wegovy pill.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
